| 期 |
栏目 |
标题 |
文件 |
| 卷 15, 编号 2 (2018) |
Articles |
Subcutaneous immunoglobulin for treatment of patients with primary immunodeficiencies: review of the literature and personal experience |
|
| 卷 11, 编号 6 (2014) |
Articles |
10% INTRAVENOUS IMMUNOGLOBULIN GAMUNEX IN THE TREATMENT OF PRIMARY IMMUNODEFICIENCIES PATIENTS: OWN EXPERIENCE AND LITERATURE REVIEW |
|
| 卷 7, 编号 4 (2010) |
Articles |
OLYMP programme-basic clinical immunology programme as a part of continued medical education for pediatritiansGeneral aspects of immune response generation. Clinical and laboratory assessment of immune dysfunction |
|
| 卷 16, 编号 4 (2019) |
Articles |
Х-linked lymphoproliferative syndrome. FEDERAL CLINICAL RECOMMENDATIONS, 2020 |
(Rus)
|
| 卷 17, 编号 3 (2020) |
Help to the practitioner |
Federal clinical guidelines. Primary immunodeficiency: severe combined immunodeficiency |
(Rus)
|
| 卷 18, 编号 3 (2021) |
Clinical practice guidelines |
Vaccination against COVID-19 for patients with primary immunodeficiency and hereditary angioedema: the position paper of the Russian Association of Allergology, Clinical Immunology, and the National Association of Experts in Primary Immunodeficiencies |
(Rus)
|
| 卷 18, 编号 2 (2021) |
Help to the practitioner |
Hereditary angioedema. Clinical guidelines. (D84.1) |
(Rus)
|
| 卷 20, 编号 2 (2023) |
Original studies |
Preliminary results of a non-interventional single-center study evaluating the efficacy of long-term use of lanadelumab in routine clinical practice in the Russian Federation |
(Rus)
(Eng)
|
